Scarica l'app Stockscreener
44.16
1.01%
-0.45
Dopo l'orario di chiusura:
44.16
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AMPH Giù?
Forum
Previsione
Precedente Chiudi:
$44.61
Aprire:
$44.39
Volume 24 ore:
331.83K
Relative Volume:
0.98
Capitalizzazione di mercato:
$2.12B
Reddito:
$712.89M
Utile/perdita netta:
$166.52M
Rapporto P/E:
22.65
EPS:
1.95
Flusso di cassa netto:
$178.13M
1 W Prestazione:
-9.08%
1M Prestazione:
-13.14%
6M Prestazione:
+1.56%
1 anno Prestazione:
-20.93%
Intervallo 1D:
$44.00
$44.86
Intervallo di 1 settimana:
$43.88
$49.12
Portata 52W:
$36.56
$65.92
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
Nome
Amphastar Pharmaceuticals Inc
Settore
Telefono
240-864-2600
Indirizzo
9620 MEDICAL CENTER DR, ROCKVILLE, CA
Confronta AMPH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| AMPH | 44.16 | 2.12B | 712.89M | 166.52M | 178.13M | 1.95 |
| ZTS | 176.42 | 79.51B | 9.15B | 2.43B | 2.31B | 4.92 |
| TAK | 13.53 | 42.89B | 30.27B | 1.93B | 3.45B | 0.444 |
| HLN | 9.43 | 42.57B | 14.26B | 1.55B | 0 | 0.3327 |
| TEVA | 16.49 | 18.51B | 16.77B | -959.00M | 1.37B | -2.00 |
| VTRS | 13.00 | 15.37B | 15.24B | -646.50M | 1.88B | 1.53 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-11-17 | Iniziato | BofA Securities | Neutral |
| 2023-07-25 | Ripresa | Jefferies | Buy |
| 2022-10-21 | Ripresa | Jefferies | Buy |
| 2022-07-29 | Iniziato | CapitalOne | Overweight |
| 2022-01-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-01-08 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-10-05 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2020-05-01 | Iniziato | Northland Capital | Outperform |
| 2019-03-13 | Downgrade | Needham | Buy → Hold |
| 2019-03-13 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2018-08-10 | Reiterato | Needham | Buy |
| 2018-03-13 | Reiterato | Needham | Buy |
| 2017-12-01 | Reiterato | Needham | Buy |
| 2017-11-09 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2017-09-27 | Reiterato | Needham | Buy |
| 2017-03-14 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2016-08-09 | Reiterato | Needham | Buy |
| 2016-05-10 | Reiterato | Needham | Buy |
| 2016-02-19 | Iniziato | Wells Fargo | Outperform |
| 2015-06-19 | Reiterato | Needham | Buy |
| 2015-06-03 | Iniziato | Raymond James | Strong Buy |
| 2014-07-21 | Iniziato | Needham | Buy |
Mostra tutto
Amphastar Pharmaceuticals Inc Borsa (AMPH) Ultime notizie
16,169 Shares in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Purchased by Los Angeles Capital Management LLC - MarketBeat
Amphastar Pharmaceuticals executive sells $336,929 in stock - Investing.com
Amphastar Pharmaceuticals director Richard Prins sells $243,985 in stock - Investing.com India
Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference - AccessWire
Amphastar Pharmaceuticals to Present at Jefferies London Healthcare Conference | AMPH Stock News - StockTitan
Amphastar Pharmaceuticals Inc (AMPH) Stock Price Down 3.5% on No - GuruFocus.com
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by US Bancorp DE - Defense World
FDA Approves Amphastar's New Epinephrine Drug, Boosting Market Growth - openPR
Here's What Key Metrics Tell Us About Amphastar (AMPH) Q3 Earnings - MSN
Amphastar Pharmaceuticals Reports Strong Q3 2024 Results - TipRanks
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by New York State Teachers Retirement System - Defense World
Insider Selling: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) EVP Sells 5,214 Shares of Stock - MarketBeat
William J. Peters Sells 7,426 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stock - MarketBeat
Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Stock's On An Uptrend: Are Strong Financials Guiding The Market? - Simply Wall St
Amphastar Pharmaceuticals executive sells $271,388 in stock By Investing.com - Investing.com Nigeria
Amphastar Pharmaceuticals executive sells $271,388 in stock - Investing.com
Amphastar CFO William J. Peters sells shares for $386,523 - Investing.com
Amphastar CFO William J. Peters sells shares for $386,523 By Investing.com - Investing.com Canada
Amphastar Pharmaceuticals Inc (AMPH) Shares Up 3.62% on Nov 8 - GuruFocus.com
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q3 2024 Earnings Call Transcript - Insider Monkey
Amphastar Pharmaceuticals Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
Amphastar Pharmaceuticals (NASDAQ:AMPH) Shares Gap DownTime to Sell? - MarketBeat
Amphastar: Q3 Earnings Snapshot - Houston Chronicle
Amphastar Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Amphastar Pharmaceuticals (AMPH) Lags Q3 Earnings and Revenue Estimates - Yahoo Finance
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2024 - AccessWire
Amphastar Q3 Revenue Hits $191.2M; BAQSIMI Sales Shine as Board Boosts Buyback Program | AMPH Stock News - StockTitan
Hyaluronidase Market Set for Rapid Expansion (2024-2031): - openPR
Amphastar Pharmaceuticals Inc (AMPH) Q3 2024 Earnings Report Pre - GuruFocus.com
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Bought by Mirae Asset Global Investments Co. Ltd. - Defense World
Amphastar Pharmaceuticals Inc (AMPH) Q3 2024 Earnings Report Preview: What to Expect - Yahoo Finance
Amphastar Pharmaceuticals (NASDAQ:AMPH) Rating Lowered to “Hold” at StockNews.com - Defense World
Amphastar Pharmaceuticals (NASDAQ:AMPH) Downgraded to Hold Rating by StockNews.com - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Purchased by Raymond James & Associates - Defense World
Allspring Global Investments Holdings LLC Trims Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
International Assets Investment Management LLC Buys Shares of 22,809 Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Trend Tracker for (AMPH) - Stock Traders Daily
Amphastar Pharmaceuticals (AMPH) Set to Announce Quarterly Earnings on Wednesday - MarketBeat
Amphastar Pharmaceuticals (AMPH) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6, 2024 - AccessWire
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by Assenagon Asset Management S.A. - MarketBeat
Boston Trust Walden Corp Purchases Shares of 539,639 Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Are Investors Undervaluing Amphastar Pharmaceuticals (AMPH) Right Now? - Yahoo Finance
Amphastar: Objectively Undervalued But For Good Reason (Rating Downgrade) (AMPH) - Seeking Alpha
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Bought by Moody Aldrich Partners LLC - MarketBeat
Possible Bearish Signals With Amphastar Pharmaceuticals Insiders Disposing Stock - Simply Wall St
nVerses Capital LLC Buys 400 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Will Amphastar (AMPH) Beat Estimates Again in Its Next Earnings Report? - MSN
(AMPH) Investment Report - Stock Traders Daily
GAMMA Investing LLC Increases Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock Rating Upgraded by StockNews.com - MarketBeat
Amphastar Pharmaceuticals Inc Azioni (AMPH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.79%
0.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):